448 related articles for article (PubMed ID: 16631060)
21. Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models.
Monnet D; Tépenier L; Brézin AP
J Cataract Refract Surg; 2009 Apr; 35(4):677-81. PubMed ID: 19304088
[TBL] [Abstract][Full Text] [Related]
22. Perioperative subconjunctival triamcinolone acetonide injection for prevention of inflammation and macular oedema after cataract surgery.
Lindholm JM; Taipale C; Ylinen P; Tuuminen R
Acta Ophthalmol; 2020 Feb; 98(1):36-42. PubMed ID: 31210019
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of cataract surgery and intraocular lens implantation with and without intracameral triamcinolone in pediatric eyes.
Dixit NV; Shah SK; Vasavada V; Vasavada VA; Praveen MR; Vasavada AR; Trivedi RH
J Cataract Refract Surg; 2010 Sep; 36(9):1494-8. PubMed ID: 20692560
[TBL] [Abstract][Full Text] [Related]
24. Comparison of orbital floor triamcinolone acetonide and oral prednisolone for cataract surgery management in patients with non-infectious uveitis.
Roesel M; Heinz C; Koch JM; Heiligenhaus A
Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):715-20. PubMed ID: 20082200
[TBL] [Abstract][Full Text] [Related]
25. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation.
Tan DT; Chee SP; Lim L; Lim AS
Ophthalmology; 1999 Feb; 106(2):223-31. PubMed ID: 9951469
[TBL] [Abstract][Full Text] [Related]
26. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
Miyake K; Ota I; Miyake G; Numaga J
J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758
[TBL] [Abstract][Full Text] [Related]
27. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ
Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
[TBL] [Abstract][Full Text] [Related]
28. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation.
Miyake K; Nishimura K; Harino S; Ota I; Asano S; Kondo N; Miyake S
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5647-52. PubMed ID: 18055815
[TBL] [Abstract][Full Text] [Related]
29. [Differential treatment of postoperative and uveitis-induced inflammatory cystoid macular edema].
Guex-Crosier Y; Othenin-Girard P; Herbort CP
Klin Monbl Augenheilkd; 1992 May; 200(5):367-73. PubMed ID: 1614102
[TBL] [Abstract][Full Text] [Related]
30. Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study.
Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
Ophthalmic Res; 2009; 42(2):81-6. PubMed ID: 19478546
[TBL] [Abstract][Full Text] [Related]
31. Cataract surgery in uveitis.
Roesel M; Heinz C; Koch JM; Heiligenhaus A
Ophthalmology; 2008 Aug; 115(8):1431, 1431.e1. PubMed ID: 18675697
[No Abstract] [Full Text] [Related]
32. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
33. Steroid prophylaxis in eyes with uveitis undergoing phacoemulsification.
Meacock WR; Spalton DJ; Bender L; Antcliff R; Heatley C; Stanford MR; Graham EM
Br J Ophthalmol; 2004 Sep; 88(9):1122-4. PubMed ID: 15317700
[TBL] [Abstract][Full Text] [Related]
34. Effects of intracameral triamcinolone and gentamicin injections following cataract surgery.
Simaroj P; Sinsawad P; Lekhanont K
J Med Assoc Thai; 2011 Jul; 94(7):819-25. PubMed ID: 21774289
[TBL] [Abstract][Full Text] [Related]
35. ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema.
Kim JE; Pollack JS; Miller DG; Mittra RA; Spaide RF;
Retina; 2008 May; 28(5):735-40. PubMed ID: 18463518
[TBL] [Abstract][Full Text] [Related]
36. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
37. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
[TBL] [Abstract][Full Text] [Related]
38. Improvement of visual acuity one-year after vitreous surgery in eyes with residual triamcinolone acetonide at the macular hole.
Hikichi T; Furukawa Y; Ohtsuka H; Higuchi M; Matsushita T; Ariga H; Kosaka S; Matsushita R
Am J Ophthalmol; 2008 Feb; 145(2):267-272. PubMed ID: 18054886
[TBL] [Abstract][Full Text] [Related]
39. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.
Lee J; Freeman WR; Azen SP; Chung EJ; Koh HJ
Retina; 2007; 27(9):1205-13. PubMed ID: 18046226
[TBL] [Abstract][Full Text] [Related]
40. The -174G/C interleukin-6 promoter polymorphism influences the development of macular oedema following uncomplicated phacoemulsification surgery.
Masood I; Negi A; Vernon SA; Comeglio P; Child AH
Eye (Lond); 2007 Nov; 21(11):1412-5. PubMed ID: 17024220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
